Chemoresection is a minimally invasive option that may reduce the need for TURBT without compromising oncologic outcomes in selected patients with intermediate-risk recurrent Ta NMIBC. For select ...

Background/Objectives: Non-muscle invasive bladder cancer (NMIBC) is characterized by high recurrence rates, requiring frequent diagnostic and therapeutic interventions. This study evaluates the ...

For patients with interstitial cystitis (IC), longer cystoscopic hydrodistention (HD) times may result in improved efficacy and longer symptom relief, according to a study published online Nov. 29 in ...

The bladder is easy to overlook – until it starts causing trouble. This small, balloon-like organ in the lower urinary tract quietly stores and releases urine, helping the body eliminate waste and ...

Experts weigh in on whether proactive peeing affects your bladder health. Ask Well Experts weigh in on whether proactive peeing affects your bladder health. Credit...Joyce Lee for The New York Times ...

Pain control was achieved by TUF in 70.0 percent of 240 patients; 18 patients underwent cystectomy for intractable pain. (HealthDay News) — For patients with interstitial cystitis (IC), transurethral ...

Pain control with transurethral fulguration was achieved by 168 of the 240 patients (70.0%). HealthDay News — For patients with interstitial cystitis (IC), transurethral fulguration (TUF) is effective ...

MONDAY, May 5, 2025 (HealthDay News) — For patients with interstitial cystitis (IC), transurethral fulguration (TUF) is effective for alleviating pelvic pain, according to a study published online ...

For patients with interstitial cystitis (IC), transurethral fulguration (TUF) is effective for alleviating pelvic pain, according to a study published online April 3 in Neurourology and Urodynamics.

The case description for a Case Records of the Massachusetts General Hospital appears below. A 72-year-old woman with type 2 diabetes had somnolence after a urologic procedure for bladder cancer. She ...

from 2009-2022 assessing patients treated with BCG for primary NMIBC. In the study, 4318 patients from the Danish registry were identified with a first-time NMIBC diagnosis that were treated with BCG.

Press Release - Oslo, Norway, March 24, 2025: Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces two abstract presentations at the 2025 European Association of Urology congress (EAU) in ...